Artivion (AORT) has closed its $175 million acquisition of Endospan, the companies said Monday.
The deal includes the potential for up to $200 million in additional payments based on the performance of Endospan's NEXUS heart surgery technology over the next two years, the companies said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments